TNNT2 and cancer: Our results demonstrate that higher baseline levels of hs-cTnT and NT-proBNP are strong predictors of an increased risk of developing incident cancer events in a prospective, multiethnic, community-based cohort free of clinical CVD, even after comprehensive multivariable adjustment.